Abstract:The myelin and lymphocyte protein MAL is a small proteolipid of 17 kDa and is expressed by oligodendrocytes and Schwann cells. We have characterized the embryonic and postnatal expression of MAL in the rat nervous system by in situ hybridization, immunocytochemistry, and western blotting and compared it with that of other myelin constituents. In the CNS, MAL is expressed during late steps of myelination: MAL protein appears ϳ3-5 days later than myelin basic protein and proteolipid protein. In contrast, in the PNS, MAL transcript and protein expression is detected prior to the onset of myelination, as early as embryonic day 17. Our results demonstrate that MAL is differentially expressed in oligodendrocytes and Schwann cells, likely reflecting different functions of the MAL proteolipid: (1) The late expression of MAL protein in the CNS points to a role in the final steps of myelin sheath formation, such as stabilization of the compacted myelin membranes. (2) The early expression of MAL protein in immature Schwann cells suggests an important role of MAL in the terminal differentiation step of the Schwann cell lineage and in the onset of peripheral myelination. Key Words: MAL-Myelin-Proteolipid-Schwann cell-GlycosphingolipidsOligodendrocyte. J. Neurochem. 73, 587-597 (1999).Myelination, the spiral wrapping of oligodendrocyte and Schwann cell processes around an axon segment, is strongly dependent on the timely and correct expression of a series of myelin proteins by these cells. A typical sequence of appearance of myelin proteins and lipids has been shown in cultured oligodendrocytes (for review, see Pfeiffer et al., 1993;Miller, 1996) as well as in the CNS in vivo (Schwab and Schnell, 1989). PNS and CNS myelin have the same specific lipid composition and are rich in glycosphingolipids (galactocerebroside, sulfatide) and cholesterol (Norton and Cammer, 1984), but differ in protein composition. The major structural myelin proteins are the proteolipid protein (PLP) and the myelin basic proteins (MBPs) in the CNS and the peripheral myelin proteins P 0 and peripheral myelin protein 22 (PMP22) in the PNS. Absence or mutations of any of these proteins can result in myelin disorders, as observed in animal models and severe human diseases (for review, see Suter and Snipes, 1995;Scherer, 1997). Important functional roles for myelin formation and function have also been attributed to minor myelin constituents (for review, see Pfeiffer et al., 1993;Mirsky and Jessen, 1996) and have motivated the search for new myelinrelated genes.The MAL cDNA has been cloned in our laboratory from a spinal cord library in a screen for novel oligodendrocyte-specific genes (Schaeren-Wiemers et al., 1995a). It encodes a new myelin protein that is expressed in Schwann cells and oligodendrocytes (Kim et al., 1995;Schaeren-Wiemers et al., 1995b). In the adult nervous system, MAL is located predominantly in the compact myelin and is a proteolipid protein (Frank et al., 1998). Several reports have demonstrated MAL expression outside the nerv...